New drug approvals: July 2018
July has seen a plethora of new drug approvals, including the US FDA's approval of iobenguane I 131, the first and only treatment for a rare adrenal cancer. Find out more in this round-up of the new therapies on the market.
Please sign in or register for FREE
Sign in to RxNet
Not yet a member? Become a member FREE to:
- Get unlimited access to ALL CONTENT
- Read selected articles from journals such as Future Medicinal Chemistry FREE
- Receive a weekly email roundup of the latest news and expert opinions
Did you know?
Your RxNet account also gives you access to communities on regenerative medicine, real-world evidence and 3D printing in medicine. Find out more>>